Microbiome | NORA Lab

Overview

In collaboration with MFM, NORA is developing a translational research line on the microbiome in neurosurgical disease, with an initial focus on neurovascular conditions such as cerebral cavernous malformations. The aim is to understand whether gut microbiome patterns and related inflammatory signals are associated with disease phenotype, haemorrhagic presentation, symptom burden and recovery.

Objectives

01. Build well-phenotyped cohorts for cerebral cavernous malformations and selected neurovascular conditions with clinically meaningful longitudinal outcomes.

02. Integrate clinical, imaging and perioperative variables with microbiome-related data whenever protocol and ethics approval allow.

03. Explore whether microbiome-associated patterns correlate with haemorrhage history, lesion multiplicity, seizures, neurological deficit or postoperative recovery.

04. Generate concrete hypotheses for future mechanistic work and independent multicentre validation.

Research direction

This programme remains exploratory, but it is deliberately anchored to concrete neurovascular questions rather than generic biomarker discovery. By linking microbiome data to clearly defined phenotypes, NORA aims to create a rigorous translational platform that could support future biomarker and outcome studies.

MFM collaboration page

Collaboration

As the protocols mature, centres with expertise in neurovascular disease, cavernous malformations or biospecimen-driven translational research may contribute to cohort development, data harmonisation and validation studies. Project-specific collaboration depends on governance, ethics approval and data-sharing agreements.